Holen Sie sich die Stockscreener-App
0.708
1.87%
0.013
Handel nachbörslich:
.69
-0.018
-2.54%
Schlusskurs vom Vortag:
$0.695
Offen:
$0.6857
24-Stunden-Volumen:
63,383
Relative Volume:
0.11
Marktkapitalisierung:
$1.86M
Einnahmen:
$574.20K
Nettoeinkommen (Verlust:
$-7.15M
KGV:
-0.0446
EPS:
-15.8778
Netto-Cashflow:
$-7.00M
1W Leistung:
-0.30%
1M Leistung:
-64.95%
6M Leistung:
-70.25%
1J Leistung:
-42.20%
1-Tages-Spanne:
$0.6835
$0.72
1-Wochen-Bereich:
$0.64
$0.7999
52-Wochen-Spanne:
$0.5079
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Firmenname
Aethlon Medical Inc
Sektor
Branche
Telefon
619-941-0360
Adresse
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.708 | 1.86M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | H.C. Wainwright | Neutral |
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent - TradingView
Aethlon Medical (AEMD) launches $0.71 unit offering registering 11.2M shares - Stock Titan
[EFFECT] AETHLON MEDICAL INC SEC Filing - Stock Titan
AEMDAethlon Medical Inc Latest SEC Filings - Finviz
Aethlon Medical prices $4M follow-on offering at $0.7101 - scanx.trade
Aethlon Medical prices $4M follow-on offering at $0.71 per share - Investing.com
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - Yahoo Finance
AEMD Q2 2026 Earnings: EPS Beat Highlights Cost Discipline Amid Pre-Revenue PhaseEarnings Preview - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Form 4 Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax - Stock Titan
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax withholding - Stock Titan
Director at Aethlon Medical (AEMD) forfeits 1,091 shares for tax withholding - Stock Titan
Form S-1/A AETHLON MEDICAL For: 1 July By Investing.com - Investing.com UK
Aethlon Medical (AEMD) updates S-1 with auditor consent, expenses - Stock Titan
Form S-1/A Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (NASDAQ: AEMD) targets $4M unit offering of shares and warrants - Stock Titan
AEMD Q2 2021 Earnings Call - BigGo ファイナンス
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Aethlon Medical (AEMD) Slides 2.22% as Support Level Nears – Key Levels in FocusImbalance Zone - dars.gov.et
Aethlon Medical (AEMD) Reveals Key Research on Long COVID and Ex - GuruFocus
Aethlon Medical study links device to Long COVID markers - Investing.com UK
Aethlon Medical reports two-fold Long COVID signal - grafa.com
Breakthrough Long COVID Biomarker Identified by Aethlon Medical (Nasdaq: AEMD) Opens Door for Hemopurifier Treatment - Investorideas.com
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance - Investorideas.com
Aethlon Medical study links device to Long COVID markers By Investing.com - Investing.com Canada
Aethlon study links Long COVID vesicles to Hemopurifier capture - Stock Titan
Price to sales forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Price to earnings forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Aethlon Medical tracks Ebola outbreak, readies Hemopurifier talks - Stock Titan
Aethlon Medical, Inc. Actuals & Estimates (NASDAQ:AEMD) - TradingView
Enterprise value to EBIT forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
AEMD Forecast — Price Target — Prediction for 2027 - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Form S-1 Aethlon Medical Inc For: 22 June By Investing.com - Investing.com Nigeria
Aethlon Medical (AEMD) files S-1 for $12M stock and warrant offering - Stock Titan
Aethlon Medical | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
Aethlon Medical (AEMD) Slips 1.05% as Shares Test Key Support Near $1.80Initial Balance - dars.gov.et
AEMD News | AETHLON MEDICAL INC (NASDAQ:AEMD) - ChartMill
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion - Proactive financial news
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aethlon Medical Inc (AEMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aethlon Medical Inc (AEMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aethlon Medical Inc (AEMD) Institutional Confidence - TradingKey
Aethlon Medical Inc (AEMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Str - GuruFocus
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionCash Flow Report - newsline.com
AEMD Q1 2026 Earnings: Slight EPS Beat Amid Pre-Revenue Status, Stock Gains Over 6%Revenue Estimate Trend - lwvtexas.org
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):